# Author Correction: A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications

**Authors:** Mani Iyer Prasanth, Dhammika Leshan Wannigama, Angela Michelle Reiersen, Premrutai Thitilertdecha, Anchalee Prasansuklab, Tewin Tencomnao, Sirikalaya Brimson, James Michael Brimson

PMC · DOI: 10.1038/s41598-024-67936-4 · 2024-07-22

## Full-text entities

- **Diseases:** COVID-19 clinical deterioration (MESH:D000086382), death (MESH:D003643), Long-COVID complications (MESH:D000094024)
- **Chemicals:** fluvoxamine (MESH:D016666)

---
Source: https://tomesphere.com/paper/PMC11263361